CY1120150T1 - Νεο συστημα χορηγησης φαρμακου βασισμενο στο ιομορφο σωματιδιο (vlp) του ιου jcv - Google Patents
Νεο συστημα χορηγησης φαρμακου βασισμενο στο ιομορφο σωματιδιο (vlp) του ιου jcvInfo
- Publication number
- CY1120150T1 CY1120150T1 CY20181100133T CY181100133T CY1120150T1 CY 1120150 T1 CY1120150 T1 CY 1120150T1 CY 20181100133 T CY20181100133 T CY 20181100133T CY 181100133 T CY181100133 T CY 181100133T CY 1120150 T1 CY1120150 T1 CY 1120150T1
- Authority
- CY
- Cyprus
- Prior art keywords
- vlp
- iomorphic
- jcv
- particle
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
- C12N2710/22042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
- C12N2710/22043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22071—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24071—Demonstrated in vivo effect
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Η εφεύρεση σχετίζεται με ένα ιόμορφο σωματίδιο (VLP) που προέρχεται από ιό ανθρώπινου πολυώματος φορτωμένο με ένα φάρμακο (φορτίο) ως ένα σύστημα χορήγησης φαρμάκων για τη μεταφορά του εν λόγω φαρμάκου στο ΚΝΣ, ιδιαίτερα των εν ζωή ανθρώπων.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12001507.8A EP2636746A1 (en) | 2012-03-06 | 2012-03-06 | A novel drug delivery system based on JCV-VLP |
EP13714195.8A EP2823048B1 (en) | 2012-03-06 | 2013-03-06 | A novel drug delivery system based on jcv-vlp |
PCT/EP2013/000656 WO2013131644A1 (en) | 2012-03-06 | 2013-03-06 | A novel drug delivery system based on jcv-vlp |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1120150T1 true CY1120150T1 (el) | 2018-12-12 |
Family
ID=48047958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20181100133T CY1120150T1 (el) | 2012-03-06 | 2018-02-05 | Νεο συστημα χορηγησης φαρμακου βασισμενο στο ιομορφο σωματιδιο (vlp) του ιου jcv |
Country Status (25)
Country | Link |
---|---|
US (3) | US20150045417A1 (el) |
EP (3) | EP2636746A1 (el) |
JP (1) | JP6175080B2 (el) |
KR (1) | KR102058488B1 (el) |
CN (1) | CN104395475B (el) |
AU (1) | AU2013230232B2 (el) |
BR (1) | BR112014021497A2 (el) |
CA (1) | CA2865564C (el) |
CY (1) | CY1120150T1 (el) |
DK (2) | DK2823048T3 (el) |
EA (1) | EA035308B1 (el) |
ES (2) | ES2658941T3 (el) |
HK (1) | HK1208046A1 (el) |
HR (1) | HRP20180221T1 (el) |
HU (2) | HUE038284T2 (el) |
LT (1) | LT2823048T (el) |
MX (1) | MX354004B (el) |
NO (1) | NO2823048T3 (el) |
NZ (1) | NZ629255A (el) |
PL (1) | PL2823048T3 (el) |
PT (2) | PT2823048T (el) |
SG (3) | SG10202102293QA (el) |
SI (1) | SI2823048T1 (el) |
TR (1) | TR201802849T4 (el) |
WO (1) | WO2013131644A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3031820A1 (en) * | 2014-12-08 | 2016-06-15 | Life Science Inkubator | JC Polyomavirus VLP (virus-like particle) with a targeting peptide |
EP3031821A1 (en) * | 2014-12-08 | 2016-06-15 | Life Science Inkubator | polyomavirus VLPs with a fusion protein |
US20180320199A1 (en) * | 2015-10-28 | 2018-11-08 | Life Science Inkubator Gmbh | Use of vlp for the detection of nucleic acids |
CN106048093A (zh) * | 2016-08-02 | 2016-10-26 | 北京思尔成生物技术有限公司 | Jc病毒的检测方法、试剂盒及其应用 |
ES2933275T3 (es) | 2018-12-18 | 2023-02-03 | Neuway Pharma Gmbh | Un sistema de suministro de fármacos novedoso y métodos para proporcionar los mismos |
EP3670652A1 (en) * | 2018-12-18 | 2020-06-24 | NEUWAY Pharma GmbH | Vlp for the treatment of a lysosomal storage disease |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19543553B4 (de) | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
JP2002500637A (ja) | 1997-04-26 | 2002-01-08 | アールピーエムエス テクノロジー リミテッド | 遺伝物質のデリバリー用パポバウイルスカプシド蛋白質の使用 |
DE19916224C1 (de) | 1999-04-10 | 2000-06-21 | November Ag Molekulare Medizin | Synthetisches biologisch aktives Molekül |
DE10131145B4 (de) * | 2001-06-28 | 2005-07-14 | Innovent E.V. | Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen |
AU2003238008A1 (en) * | 2002-06-12 | 2003-12-31 | Temple University Of The Commonwealth System Of Higher Education | Method of cell growth inhibition with agnoprotein |
EP2036980A1 (de) | 2007-09-14 | 2009-03-18 | Gruber, Jens | Herabregulation der Genexpression mittels Nukleinsäure-beladener virusähnlicher Partikel |
EP2093780B1 (en) | 2008-02-22 | 2014-11-05 | ABB Technology AG | A spring drive unit, an operating device for an electrical switching apparatus, and method for charging and/or discharging a spring in an operating device for an electrical switching apparatus |
CN102369436B (zh) * | 2009-02-05 | 2014-10-22 | 生物基因Idecma公司 | 用于检测jc多瘤病毒的方法 |
-
2012
- 2012-03-06 EP EP12001507.8A patent/EP2636746A1/en not_active Withdrawn
-
2013
- 2013-03-06 SG SG10202102293QA patent/SG10202102293QA/en unknown
- 2013-03-06 PT PT137141958T patent/PT2823048T/pt unknown
- 2013-03-06 MX MX2014010651A patent/MX354004B/es active IP Right Grant
- 2013-03-06 EP EP17200325.3A patent/EP3299468A1/en not_active Withdrawn
- 2013-03-06 KR KR1020147028123A patent/KR102058488B1/ko active IP Right Grant
- 2013-03-06 CN CN201380013112.4A patent/CN104395475B/zh active Active
- 2013-03-06 BR BR112014021497A patent/BR112014021497A2/pt not_active IP Right Cessation
- 2013-03-06 EA EA201491636A patent/EA035308B1/ru unknown
- 2013-03-06 PL PL13714195T patent/PL2823048T3/pl unknown
- 2013-03-06 DK DK13714195.8T patent/DK2823048T3/en active
- 2013-03-06 SG SG11201405255SA patent/SG11201405255SA/en unknown
- 2013-03-06 EP EP13714195.8A patent/EP2823048B1/en active Active
- 2013-03-06 US US14/383,267 patent/US20150045417A1/en not_active Abandoned
- 2013-03-06 SI SI201330942T patent/SI2823048T1/en unknown
- 2013-03-06 CA CA2865564A patent/CA2865564C/en active Active
- 2013-03-06 HU HUE13714195A patent/HUE038284T2/hu unknown
- 2013-03-06 ES ES13714195.8T patent/ES2658941T3/es active Active
- 2013-03-06 JP JP2014560272A patent/JP6175080B2/ja active Active
- 2013-03-06 SG SG10201607358WA patent/SG10201607358WA/en unknown
- 2013-03-06 WO PCT/EP2013/000656 patent/WO2013131644A1/en active Application Filing
- 2013-03-06 NO NO13714195A patent/NO2823048T3/no unknown
- 2013-03-06 NZ NZ629255A patent/NZ629255A/en not_active IP Right Cessation
- 2013-03-06 LT LTEP13714195.8T patent/LT2823048T/lt unknown
- 2013-03-06 AU AU2013230232A patent/AU2013230232B2/en not_active Ceased
- 2013-03-22 DK DK13001491.3T patent/DK2774991T3/en active
- 2013-03-22 TR TR2018/02849T patent/TR201802849T4/tr unknown
- 2013-03-22 PT PT130014913T patent/PT2774991T/pt unknown
- 2013-03-22 HU HUE13001491A patent/HUE038580T2/hu unknown
- 2013-03-22 ES ES13001491.3T patent/ES2661389T3/es active Active
-
2015
- 2015-08-31 HK HK15108461.6A patent/HK1208046A1/xx not_active IP Right Cessation
-
2018
- 2018-02-05 CY CY20181100133T patent/CY1120150T1/el unknown
- 2018-02-06 HR HRP20180221TT patent/HRP20180221T1/hr unknown
- 2018-06-26 US US16/018,110 patent/US20180296700A1/en not_active Abandoned
-
2019
- 2019-03-15 US US16/354,739 patent/US11291735B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120150T1 (el) | Νεο συστημα χορηγησης φαρμακου βασισμενο στο ιομορφο σωματιδιο (vlp) του ιου jcv | |
CY1123434T1 (el) | Λυοφιλοποiημενα νανοεναιωρηματα φαρμακων | |
CY1119577T1 (el) | Συν-αγωνιστες υποδοχεα γλυκαγονης/glp-1 | |
MD4589C1 (ro) | Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C | |
EA201690780A1 (ru) | Пегилированные лекарственные средства-линкеры для улучшенной фармакокинетики конъюгатов лиганд-лекарственное средство | |
IL245347B (en) | Continuous oral drug delivery | |
HK1218850A1 (zh) | 持續藥物遞送植入物 | |
DK2925272T3 (da) | Lægemiddelopbevarings-, udleverings- og administrationssystem | |
TR201903569T4 (tr) | Bir gecikmeli salım ilaç formülasyonu. | |
EA201400591A1 (ru) | Ингалятор | |
HK1213480A1 (zh) | 用於持續釋放蛋白質的生物可降解的藥物遞送系統 | |
EP2968162A4 (en) | Multi-stage biodegradable drug delivery platform | |
MX2015017540A (es) | Formulacion de relacion fija de insulina glargina-lixisenatida. | |
CY1120278T1 (el) | Συστημα χορηγησης φαρμακου για χρηση στη θεραπεια ή στη διαγνωση νευρολογικων διαταραχων | |
SG11201508344PA (en) | Polysialic acid, blood group antigens and glycoprotein expression | |
PH12017501084A1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
ECSP15010550A (es) | Preparación farmacéutica sólida que contiene levotiroxina | |
HK1191868A1 (zh) | 芍藥苷類化合物在製備抗腫瘤藥物中的用途 | |
PH12016500847A1 (en) | Multi-particulate drug delivery system | |
FI20126169A (fi) | Lääkejakelujärjestelmä | |
PH12015501313B1 (en) | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration | |
DK2953617T3 (da) | Farmaceutiske sammensætninger, der inkorporerer lavdosislægemidler | |
Ren | THE ASYMPTOTIC STABILITY REGION TO A CLASS OF HIGHER ORDER DELAY LINEAR DIFFERENCE EQUATIONS | |
IN2013CH01516A (el) | ||
GB201510641D0 (en) | Inhalation device for administering sustained release drug delivery to the lungs |